Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21WAF1/CIP1 and proliferating cell nuclear antigen-Reference-Cited by-同舟云学术

Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21WAF1/CIP1 and proliferating cell nuclear antigen

Published:2009-11 Issue:1 Volume:285 Page:66-72
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Masuo Takashige,Okamura Shinichi,Zhang Yajing,Mori Masatomo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. Purification of cyclic 3′,5′-nucleotide phosphodiesterase inhibitory protein by affinity chromatography on activator protein coupled to sepharose;Klee;Biochemistry,1978

2. Calcineurin as a multifunctional regulator;Shibasaki;J. Biochem. (Tokyo),2002

3. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4;Shibasaki;Nature,1996

4. Calcineurin is a common target of cyclophilin–cyclosporin A and FKBP-FK506 complexes;Liu;Cell,1991

5. Activation of calcineurin expression in ischemia-reperfused rat heart and in human ischemic myocardium;Lakshmikuttyamma;J. Cell Biochem.,2003

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dephosphorylation of NFAT by Calcineurin inhibits Skp2-mediated degradation;The Journal of Biochemistry;2023-11-29

2. Differential dose–response effect of cyclosporine A in regulating apoptosis and autophagy markers in MCF-7 cells;Inflammopharmacology;2023-05-19

3. WNT16b promotes the proliferation and self‐renewal of human limbal epithelial stem/progenitor cells via activating the calcium/calcineurin A/NFATC2 pathway;Cell Proliferation;2023-03-27

4. Dephosphorylation of the EGFR protein by calcineurin at serine 1046/1047 enhances its stability;Biochemical and Biophysical Research Communications;2023-01

5. Significant position of C-myc in colorectal cancer: a promising therapeutic target;Clinical and Translational Oncology;2022-08-16